← Leaderboards
Constantinos Kurt Wibmer
Wits Health Consortium (Pty), Ltd
$373,358
Attributed
$373,358
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $146.9K · FY2019–21$200K$150K$100K$50K$0
'19
'20
'21
Funding mix
By agency
NIH$373,358 · 1
By mechanism
R21$373,358 · 1
Top collaborators
No co-investigators on record.
Most similar at Wits Health Consortium (Pty), Ltd
Same institution · by research overlap
- James Alasdair McIntyre$15,642,927
- Glenda Gray$19,001,912
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureHealthcareAffinityAnimalsAffectAfricaAnaphylaxisAntiveninsBindingBinding ProteinsChimeric ProteinsAntibodiesCountryCross ReactivityCrystallizationCrystallographyDesignDeveloping CountriesElementsEngineeringEquus CaballusExtracellular DomainFamilyHiv-1
Grant awards (3)
Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa$79,560
R21 · FY2021 · TW · contact PI
Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa$146,899
R21 · FY2020 · TW · contact PI
Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa$146,899
R21 · FY2019 · TW · contact PI